Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to the Annual General Meeting of Bioretec Ltd

Bioretec Ltd          Company announcement          18 March 2022 at 11.00 a.m. EETThe shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting of shareholders to be held on 13[th] April 2022 at 12:00 (Finnish time) at Bioretec premises in auditorium of Tampark, at Yrittäjänkulma 5, FI-33710 Tampere, Finland. A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation. A proxy representative shall present a dated power of attorney or in another reliable manner demonstrate their right to represent

Toivo Group Oyj - Managers' Transactions - Asko Myllymäki

Toivo Group Oyj - Managers' Transactions - 18 March 2022 at 11 a.m. ____________________________________________ Person subject to the notification requirement Name: Sirkka Myllymäki Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Asko Myllymäki Position: Member of the Board Issuer: Toivo Group Oyj LEI: 743700N31WYJDNPT8M98 Notification type: INITIAL NOTIFICATION Reference number: 11680/9/8 ____________________________________________ Transaction date: 2022-03-17 Venue: FIRST NORTH GROWTH MARKET

Dometic reports restated segment financials for 2019-2021

· As previously announced, Dometic will start reporting the Marine business as a separate segment from the reporting of Q1 2022. · Other global verticals and the Igloo business remain in segment Global. Segments Americas, APAC and EMEA remain as before. · The segments will be measured on EBITA before amortization of acquisition-related intangible assets and items affecting comparability starting from the reporting of Q1 2022. · To facilitate year-on-year comparisons, Dometic today discloses restated financials for 2019-2021 full year and by quarter. Restated Financials are now

Teleste Management Group nomination

TELESTE CORPORATION  PRESS RELEASE  18 MARCH 2022 AT 10:30 EET TELESTE MANAGEMENT GROUP NOMINATION Mr. Valerian Sand has been appointed as the Senior Vice President for Video Security andInformation business and member of Teleste Management Group. Valerian will begin in his role on April 1st, 2022, and he will report to the President & CEO. TELESTE CORPORATION Esa HarjuPresident & CEO ADDITIONAL INFORMATION: SVP HR Tuomas Vanne, phone +358 2 2605 611 DISTRIBUTION:Nasdaq OMXMediawww.teleste.com About Teleste Teleste offers an integrated product and service

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 71 - 18 MARCH 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)

The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Tuesday 26 April 2022 at 11.30 a.m. CEST, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. Entrance registration starts at 11.00 a.m. CEST. A lighter lunch will be served after the AGM.The Getinge Board of Directors of Getinge has decided to allow the shareholders to also attend the AGM by postal voting in accordance with the regulations in Getinge’s Articles of Association as further described below. Further information

The Nomination Committee in Tobii proposes Per Norman as new Chairman of the Board and Mats Backman as a new board member

The Nomination Committee in Tobii has completed its nomination work for the 2022 Annual General Meeting. It intends to propose to the 2022 Annual General Meeting for  Per Norman to be elected new Chairman of the Board and Mats Backman be elected as a new Board member of Tobii. Current chairman Kent Sander and board member Nils Bernhard have declined re-election. Kent Sander has been a board member and Chairman of the Board of Tobii since 2014. Nils Bernhard has been a member since 2004. The Nomination Committee would like to thank both for their contributions and commitment to the

Fortum submits the Loviisa nuclear power plant operating licence application to the Government

Fortum [Power and Heat Oy] has submitted the Loviisa nuclear power plant operating licence application to the Finnish Government on 18.3.2022.  Fortum is seeking a new operating licence for both nuclear power plant units until the end of 2050. Fortum also applies for a licence to use the low- and intermediate-level radioactive waste final disposal facility located in Loviisa’s current power plant area until 2090. “We want to support the achievement of Finland’s and Europe’s carbon neutrality targets and enable the building of a reliable, competitive and sustainable energy system,”

BioStock Investor Meeting - now available online

The BioStock team would like to take this opportunity to thank all participants for this weeks successful BioStock Investor Meeting, where 14 selected growth companies in the Nordic Life Science space presented to investors and potential partners.Did you miss the broadcast? No worries, all presentations are available on BioStock's YouTube channel . Showcasing companies included · Alzecure  · Aptahem · Carbiotix · Emplicure · Idogen · Miris · Phase Holographic Imaging  · Pharmiva · Prolight

Nightingale’s Board of Directors resolved on new share-based incentive plans

Company release, 18 March 2022 at 9:45 (EET) Based on the authorisation granted by the Extraordinary General Meeting held on 18 February 2021, Nightingale Health Plc’s (“Nightingale”) Board of Directors has resolved to launch several new stock option programs. The purpose of the stock option programs is to bind the option holders to the economic growth of Nightingale and to the development of Nightingale’s market capitalisation as well as create a long-term relationship between Nightingale and the option holders which benefits the company both economically and operationally. The maximum

Management team change for continued growth

Quartiers Properties AB (publ) (“Quartiers” or the “Company”) is implementing a management team change to centralise administrative, legal and operational support functions into a new department, and is hiring a new CFO.Carl-Fredrik Morander assumes the role of CFO. Carl-Fredrik has more than 30 years of experience in auditing, accounting and process efficiency, including as a partner at the auditing and consulting firm Rödl & Partner. Carl-Fredrik is based in Spain and has been working on the external financial reporting for Quartiers since 2017. Maria Cepero is moving from the role of

INVITATION TO SMART WIRES TECHNOLOGY LTD PRESENTATION OF THE Q4 2021 INTERIM REPORT

Smart Wires Technology Ltd (“Smart Wires”) publishes its Q4 2021 Interim Report on 24 March 2022. In connection with the publication, Smart Wires invites you to a webcast on the same day at 15:00 CET. The presentation will be held in English by Peter Wells (CEO) and Julie Andrews (CFO), followed by a Q&A session.The webcast will be held via the following link: https://tv.streamfabriken.com/smart-wires-q4-2021 . The presentation material will also be available on Smart Wires’ website https://www.smartwires.com/investors/financial-reports-presentations/. Teleconference: Dial-in number SE:

Thunderful Group welcomes Lennart Sparud as new Chief Financial Officer

Gothenburg-based gaming company Thunderful Group AB today announces the appointment of Lennart Sparud as new Chief Financial Officer (CFO). Among other merits, Lennart Sparud has served for many years as CFO at publicly listed Hexatronic Group. Thunderful’s current CFO Anders Maiqvist stays on in the role until the handover is complete.Thunderful Group AB recently presented a strong leadership team for the Games segment. The company today announces that Lennart Sparud will join as new CFO when his current employment as CFO at Profura AB expires, which will happen October 1 this year at the

Latour acquires PHS Logistiktechnik GmbH

Investment AB Latour has, through its wholly-owned subsidiary Caljan A/S, acquired 100 per cent of the shares in PHS Logistiktechnik GmbH (PHS) from Austrian Post and the two founders. PHS has developed an automatic parcel unloader used by parcel carriers. The Rapid Unloader system reduces unloading times, increases throughput, and improves the working environment in logistics centres. The company, founded in 2017, is headquartered in Graz, Austria, with 3 employees. “The acquisition of PHS further strengthens our offering within automated parcel handling. The Rapid Unloader opens new

The Melody Club promises new experiences on Teatergatan

Glamorous Eurovision stage or secret hard rock gig, everything is now possible at Teatergatan 26. Today, Friday March 18, The Melody Club is opening to offer Gothenburgers sparkling cocktails, a wonderful food concept and an exceptional karaoke experience. With make-up, wigs and stage clothes, there are all the conditions to perform on a private stage with high-class sound quality, play plugged-in instruments and personally choose the stage lights for the show.“Finally, we can now welcome all guests. The Melody Club is a totally unique and new experience for everyone that likes karaoke in

TF Bank publishes the 2021 Annual and Sustainability Report

The Board of Directors and CEO hereby present the 2021 Annual and Sustainability Report as well as the risk and capital adequacy report for TF Bank AB (publ). The documents have been published at www.tfbankgroup.com.“When summarising 2021, we can look back at an additional year with profitable growth. TF Bank’s loan portfolio increased by 33 % in local currencies, surpassing SEK 10 billion. At the same time, earnings per share increased by 38 % compared to 2020 and return on equity amounted to over 24 %.” – Mattias Carlsson, CEO  For further information, please contact: Mikael

Wicket Gaming ready to scale up Cricket Manager Pro in more countries after achieving milestones

18 March 2022 at 08:30 Eric de Basso, CEO of Wicket Gaming, updates the status of the company's upscaling of Cricket Manager Pro 2022.Cricket Manager Pro 2022 Wicket Gaming has secured several important milestones in recent weeks. Among other things, the previously announced collaboration with the cricket world star AB de Villiers has been taken to the next step. AB de Villiers is now implemented in the game and will be on its cover going forward. Another important milestone has been the implementation of the feedback received from the test market in South Africa. This feedback has

Publication of Studsvik's Annual Report for 2021

Studsvik's Annual Report for 2021 has been published and is available at www.studsvik.com. The printed version of the Annual Report will be distributed to shareholders upon request. This information is information that Studsvik AB (publ) is obliged to disclose pursuant to the Securities Market Act. The information was released for public disclosure, through the agency of the contact person below, on March 18, 2022, at 08:30 (CET). ___________________________________________ For further information please contact: Niklas Karlsson, CFO, + 46 760 02 10 53

Inhalation Research Services signs new order worth 74 000 EUR with leading Swiss generics company

(Stockholm, 18 March 2022) Inhalation Research Services (IRS) has signed a contract worth 74 000 Euros for a research project with a leading developer of inhaled generics. The project will compare in vitro data from ISAB’s dissolution module DissolvIt® with in vivo data from healthy volunteers, producing more milestone evidence of DissolvIt’s ability to produce predictive IVIVC (In Vitro-In Vivo Correlated) data. In January 2022 ISAB submitted a White Paper to the FDA aiming to validate DissolvIt® to become a recommended dissolution method for inhaled drug tests.IRS, the Contract Research

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital18 March 2022 at 9.15 EET Nordea Bank Abp (“Nordea”) has today cancelled 32,665,816 treasury shares, which were held for capital optimisation purposes and acquired through share buy-backs, in line with the decision by the Board of Directors. The cancellation of the treasury shares has been registered with the Finnish Trade Register on 18 March 2022. After the cancellation, the total number of shares in Nordea is 3,860,317,333 and the total number of votes attached to the shares is 3,860,317,333.

STRONG END TO A STRONG YEAR

This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version governs. FOURTH QUARTER, OCTOBER – DECEMBER 2021 · Net sales increased by 16.1%, or 17.3% FX adjusted, to MSEK 78.7 (67.8) · Gross profit increased by 25.4%, or 26.9% FX adjusted, to MSEK 63.1 (50.3) · EBIT increased to MSEK 10.7 (5.4) · Earnings after tax was MSEK 10.5 (4.3) · Earnings per share was, basic SEK 1.33 (0.55), diluted SEK 1.33 (0.55) FULL YEAR, JANUARY – DECEMBER 2021 · Net sales increased by 14.2%, or 15.2% FX adjusted, to MSEK

Updated regulatory plans for NEFECON in China

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that partner Everest Medicines (HKEX 1952.HK) plans to submit an NDA for NEFECON in China in the second half of 2022.Everest received Breakthrough Therapy Designation (BTD) from the China Center for Drug Evaluation, National Medical Products Administration (CDE,NMPA) in December, 2020 and have completed enrollment of the 60 Chinese patients required to complement the submission of the global data set from the NefIgArd trial. Everest plans to conduct an interim analysis of the Chinese patients

There are no items matching the current filter
There are no more items matching the current filter
Back to top